Harry Fischl

Harry Fischl has a diverse work experience in the scientific field. Harry is currently working as a Senior Scientist at STORM Therapeutics Limited, a position they started in April 2022. Previously, they served as a Bioinformatics Scientist at Illumina from January 2021 to April 2022. Prior to that, Harry worked as a Postdoctoral Research Associate at the University of Oxford from January 2016 to January 2021.

Harry Fischl obtained their Bachelor of Arts degree in Biochemistry from the University of Cambridge in 2010. Harry then pursued a higher degree and completed their MSci in Biochemistry at the University of Cambridge in 2011. Continuing their academic journey, Harry obtained their Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from the University of Oxford in 2015.